SCHEMBL15610936

SCHEMBL15610936

COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)OP(=O)(O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB1 Q9H4B7 13/20 0.56
TUBB4A P04350 7/20 0.56
TUBB P07437 7/20 0.56
TUBA3C P0DPH7 7/20 0.56
TUBA1B P68363 7/20 0.56
TUBA4A P68366 7/20 0.56
TUBB4B P68371 7/20 0.56
TUBB3 Q13509 7/20 0.56
TUBB2A Q13885 7/20 0.56
TUBB8 Q3ZCM7 7/20 0.56
TUBA3E Q6PEY2 7/20 0.56
TUBA1A Q71U36 7/20 0.56
TUBA1C Q9BQE3 7/20 0.56
TUBB6 Q9BUF5 7/20 0.56
TUBB2B Q9BVA1 7/20 0.56
SLC22A2 O15244 1/20 0.56
SLCO2B1 O94956 1/20 0.56
ABCB1 P08183 1/20 0.56
SLC22A6 Q4U2R8 1/20 0.56
SLC22A8 Q8TCC7 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13940886 0.92 TUBB1 (0.61) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL14175303 0.89 TUBB1 (0.58) TUBB1TUBB4ATUBBTUBA3CTUBA1B
Fosbretabulin SCHEMBL29374788 0.89 TUBB1 (0.61) TUBB1TUBB4ATUBBTUBA3CTUBA1B
Fosbretabulin SCHEMBL66079 0.89 TUBB1 (0.61) TUBB1TUBB4ATUBBTUBA3CTUBA1B
Fosbretabulin SCHEMBL29417596 0.89 TUBB1 (0.61) TUBB1TUBB4ATUBBTUBA3CTUBA1B
Fosbretabulin SCHEMBL3542758 0.88 TUBB1 (0.60) TUBB1TUBB4ATUBBTUBA3CTUBA1B
Fosbretabulin SCHEMBL3179235 0.88 TUBB1 (0.60) TUBB1TUBB4ATUBBTUBA3CTUBA1B
Fosbretabulin SCHEMBL9707816 0.88 TUBB1 (0.60) TUBB1TUBB4ATUBBTUBA3CTUBA1B
Fosbretabulin SCHEMBL9708418 0.88 TUBB1 (0.60) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL14175312 0.86 TUBB1 (0.61) TUBB1TUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10688177-B2 Naturally-occurring CpG oligonucleotide compositions and therapeutic applications thereof LABYRINTH HOLDINGS LLC (US) 2020-06-23 US disclosed
US-20180369367-A1 Naturally-Occurring CpG Oligonucleotide Compositions and Therapeutic Applications Thereof LABYRINTH HOLDINGS LLC (US) 2018-12-27 US disclosed
US-9931398-B2 Naturally-occurring CpG oligonucleotide compositions and therapeutic applications thereof LABYRINTH HOLDINGS, LLC (US) 2018-04-03 US disclosed
US-20170266277-A9 Naturally-Occurring CpG Oligonucleotide Compositions and Therapeutic Applications Thereof LABYRINTH HOLDINGS, LLC (US) 2017-09-21 US disclosed
US-20170087247-A1 Naturally-Occurring CpG Oligonucleotide Compositions and Therapeutic Applications Thereof LABYRINTH HOLDINGS, LLC (US) 2017-03-30 US disclosed
US-20140086849-A1 Naturally-Occurring CpG Oligonucleotide Compositions and Therapeutic Applications Thereof LABYRINTH HOLDINGS, LLC 2014-03-27 US disclosed